There is now increasing evidence for clustering and compartmentalization of signaling enzymes with their activators and target proteins. This targeting of enzymes with their substrates may promote specificity of signaling events (1-3). To better understand the physiological role of scaffolding proteins, such as A-kinase anchoring proteins (AKAPs), 1 which target cyclic AMP-dependent protein kinase (PKA) (2, 4), it is essential to monitor in real time the interactions between the components of this signaling complex in living cells. However, to date such measurements have not been reported for the PKA pathway. AKAPs and PKA co-localize in cells. This was first shown by the redistribution of the type II regulatory (RII) and the catalytic subunits of PKA from the cytosolic to the particulate fraction following overexpression of AKAP75 in HEK293 cells (5). In studies in HEK293 cells, S-AKAP84 targeted RII to mitochondria (6). In rat cardiac myocytes, endogenous AKAP100 co-localized with RII in the region of the junctional sarcoplasmic reticulum/transverse tubule (7). A functional role of AKAP targeting of PKA is further indicated by studies in which Ht31 peptide, a competitive inhibitor of AKAP/PKA binding, was introduced into AKAP-overexpressing cells. For example, transfection of RINm5F pancreatic beta cells with Ht31 caused redistribution of RII from a perinuclear to a diffuse cytoplasmic localization and prevented cAMP-dependent insulin secretion (8). Similarly, in cardiac myocytes transfected with AKAP79, microinjection of Ht31 impaired the PKA-dependent increase in L-type Ca 2ϩ current (9). These studies demonstrate a role for AKAPs in the regulation of PKA distribution and in the specificity of PKA function.To date, the binding of RII with full-length AKAPs or with the peptide Ht31 has been demonstrated in vitro by RII overlay assay (10 -12), by band shift assays on nondenaturing gels (12, 13), by equilibrium dialysis measurements (12, 13), and recently by solution NMR measurements of the N-terminal dimerization domain of RII with Ht31 (14). Equilibrium dialysis measurements (12) and surface plasmon resonance 2 showed that Ht31 binds RII with nanomolar affinity. Although these in vitro approaches provide evidence for high affinity RII/AKAP or RII/Ht31 interactions in vitro, the results presented here extend these studies by measuring real-time interactions between these molecules in living cells. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.ʈ To whom correspondence should be addressed: Dept.
EXPERIMENTAL PROCEDURES
Construction of Vectors for the Expression of GFP-tagged Proteins-The cDNAs for RII␣, Ht31, and Ht31P were gifts from John Scott (Vollum Institute, Howard Hughes Medical Institute, Portland, OR). The construct for Ht31, used in the FRET experiments, encodes residues 418 -718 of the human thyroid RII anchoring protein (...